![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:CDKN2D-HM13 (FusionGDB2 ID:HG1032TG81502) |
Fusion Gene Summary for CDKN2D-HM13 |
![]() |
Fusion gene information | Fusion gene name: CDKN2D-HM13 | Fusion gene ID: hg1032tg81502 | Hgene | Tgene | Gene symbol | CDKN2D | HM13 | Gene ID | 1032 | 81502 |
Gene name | cyclin dependent kinase inhibitor 2D | histocompatibility minor 13 | |
Synonyms | INK4D|p19|p19-INK4D | H13|IMP1|IMPAS|IMPAS-1|MSTP086|PSENL3|PSL3|SPP|SPPL1 | |
Cytomap | ('CDKN2D')('HM13') 19p13.2 | 20q11.21 | |
Type of gene | protein-coding | protein-coding | |
Description | cyclin-dependent kinase 4 inhibitor DCDK inhibitor p19INK4dcell cycle inhibitor, Nur77 associating proteincyclin-dependent kinase 4 inhibitor D p19cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)inhibitor of cyclin-dependent kinase 4d | minor histocompatibility antigen H13intramembrane protease 1minor histocompatibility antigen 13presenilin-like protein 3signal peptide peptidase betasignal peptide peptidase like 1 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | P55273 | . | |
Ensembl transtripts involved in fusion gene | ENST00000335766, ENST00000393599, | ||
Fusion gene scores | * DoF score | 2 X 4 X 2=16 | 16 X 19 X 12=3648 |
# samples | 3 | 25 | |
** MAII score | log2(3/16*10)=0.906890595608518 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(25/3648*10)=-3.86710572950266 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: CDKN2D [Title/Abstract] AND HM13 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | CDKN2D(10679623)-HM13(30154013), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | CDKN2D | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity | 8741839 |
Hgene | CDKN2D | GO:0000082 | G1/S transition of mitotic cell cycle | 10208428 |
Hgene | CDKN2D | GO:0007050 | cell cycle arrest | 10208428 |
Hgene | CDKN2D | GO:0008285 | negative regulation of cell proliferation | 10208428 |
Hgene | CDKN2D | GO:0030308 | negative regulation of cell growth | 10208428 |
Hgene | CDKN2D | GO:0042326 | negative regulation of phosphorylation | 10208428 |
Tgene | HM13 | GO:0033619 | membrane protein proteolysis | 14741365 |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | UCEC | TCGA-B5-A5OD-01A | CDKN2D | chr19 | 10679623 | - | HM13 | chr20 | 30154013 | + |
ChimerDB4 | UCEC | TCGA-B5-A5OD | CDKN2D | chr19 | 10679622 | - | HM13 | chr20 | 30154012 | + |
Top |
Fusion Gene ORF analysis for CDKN2D-HM13 |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5UTR-3CDS | ENST00000335766 | ENST00000335574 | CDKN2D | chr19 | 10679623 | - | HM13 | chr20 | 30154013 | + |
5UTR-3CDS | ENST00000335766 | ENST00000335574 | CDKN2D | chr19 | 10679622 | - | HM13 | chr20 | 30154012 | + |
5UTR-3CDS | ENST00000335766 | ENST00000340852 | CDKN2D | chr19 | 10679623 | - | HM13 | chr20 | 30154013 | + |
5UTR-3CDS | ENST00000335766 | ENST00000340852 | CDKN2D | chr19 | 10679622 | - | HM13 | chr20 | 30154012 | + |
5UTR-3CDS | ENST00000335766 | ENST00000376127 | CDKN2D | chr19 | 10679623 | - | HM13 | chr20 | 30154013 | + |
5UTR-3CDS | ENST00000335766 | ENST00000376127 | CDKN2D | chr19 | 10679622 | - | HM13 | chr20 | 30154012 | + |
5UTR-3CDS | ENST00000335766 | ENST00000398174 | CDKN2D | chr19 | 10679623 | - | HM13 | chr20 | 30154013 | + |
5UTR-3CDS | ENST00000335766 | ENST00000398174 | CDKN2D | chr19 | 10679622 | - | HM13 | chr20 | 30154012 | + |
5UTR-3UTR | ENST00000335766 | ENST00000492709 | CDKN2D | chr19 | 10679623 | - | HM13 | chr20 | 30154013 | + |
5UTR-3UTR | ENST00000335766 | ENST00000492709 | CDKN2D | chr19 | 10679622 | - | HM13 | chr20 | 30154012 | + |
intron-3CDS | ENST00000393599 | ENST00000335574 | CDKN2D | chr19 | 10679623 | - | HM13 | chr20 | 30154013 | + |
intron-3CDS | ENST00000393599 | ENST00000335574 | CDKN2D | chr19 | 10679622 | - | HM13 | chr20 | 30154012 | + |
intron-3CDS | ENST00000393599 | ENST00000340852 | CDKN2D | chr19 | 10679623 | - | HM13 | chr20 | 30154013 | + |
intron-3CDS | ENST00000393599 | ENST00000340852 | CDKN2D | chr19 | 10679622 | - | HM13 | chr20 | 30154012 | + |
intron-3CDS | ENST00000393599 | ENST00000376127 | CDKN2D | chr19 | 10679623 | - | HM13 | chr20 | 30154013 | + |
intron-3CDS | ENST00000393599 | ENST00000376127 | CDKN2D | chr19 | 10679622 | - | HM13 | chr20 | 30154012 | + |
intron-3CDS | ENST00000393599 | ENST00000398174 | CDKN2D | chr19 | 10679623 | - | HM13 | chr20 | 30154013 | + |
intron-3CDS | ENST00000393599 | ENST00000398174 | CDKN2D | chr19 | 10679622 | - | HM13 | chr20 | 30154012 | + |
intron-3UTR | ENST00000393599 | ENST00000492709 | CDKN2D | chr19 | 10679623 | - | HM13 | chr20 | 30154013 | + |
intron-3UTR | ENST00000393599 | ENST00000492709 | CDKN2D | chr19 | 10679622 | - | HM13 | chr20 | 30154012 | + |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for CDKN2D-HM13 |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
CDKN2D | chr19 | 10679622 | - | HM13 | chr20 | 30154012 | + | 8.08E-08 | 0.9999999 |
CDKN2D | chr19 | 10679622 | - | HM13 | chr20 | 30154012 | + | 8.08E-08 | 0.9999999 |
CDKN2D | chr19 | 10679622 | - | HM13 | chr20 | 30154012 | + | 8.08E-08 | 0.9999999 |
CDKN2D | chr19 | 10679622 | - | HM13 | chr20 | 30154012 | + | 8.08E-08 | 0.9999999 |
![]() |
![]() |
Top |
Fusion Protein Features for CDKN2D-HM13 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:10679623/:30154013) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
CDKN2D | . |
FUNCTION: Interacts strongly with CDK4 and CDK6 and inhibits them. {ECO:0000269|PubMed:7739548, ECO:0000269|PubMed:8741839}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for CDKN2D-HM13 |
![]() |
Top |
Fusion Gene PPI Analysis for CDKN2D-HM13 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CDKN2D-HM13 |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for CDKN2D-HM13 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | CDKN2D | C0024623 | Malignant neoplasm of stomach | 1 | CTD_human |
Hgene | CDKN2D | C0038356 | Stomach Neoplasms | 1 | CTD_human |
Hgene | CDKN2D | C1708349 | Hereditary Diffuse Gastric Cancer | 1 | CTD_human |